stanford school of medicine logotitle logo
advanced

 

 

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Psychiatry

 

Pulmonary/Critical Care

 

Rheumatology

Portal Vein Thrombosis & Superior Mesenteric Artery Thrombosis

 

Portal Vein Thrombosis:

  • Etiology
    • Cirrhosis (25%)
    • Hypercoagulable state: PNH, factor V Leiden, PT gene mutation, protein C deficiency
    • Malignancy
    • Collagen vascular disease: SLE, Bechet’s
    • Inflammatory focus within abdomen: pancreatitis, IBD, abdominal sepsis
    • Myeloproliferative disorders
    • Pregnancy, OCPs
  • Clinical presentation
    • Acute: typically silent, but can present with abdominal/back pain
    • Chronic: manifestations of portal hypertension (varices, splenomegaly, ascites, pylephlebitis)
  • Management
    • In acute setting, anticoagulation is indicated, as it facilitates recanalization of the thrombus, potentially averting the development of portal hypertension
    • For chronic thrombus, main goal is to treat the consequences of portal hypertension (e.g. portocaval shunt, TIPS, splenectomy, variceal banding)
      • The issue of anticoagulation is more challenging, as the potential benefit must be balanced against the risk of variceal bleeding

 

Superior Mesenteric Artery Thrombosis:

    • Etiology: typically hypercoagulable state
    • Complications: resistance to venous outflow à bowel wall edema à diminished arterial blood flow --> bowel infarction
    • Management: anticoagulation

 

(Christopher Woo MD, 4/14/11)